Nuvessa - (1.30% ; Vaginal Gel)

Generic Name	Metronidazole	Innovator	Chemo Research
Dosage	1.30% ; Vaginal Gel	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	None	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	None
Indication	Metronidazole vaginal gel 1.3% is a nitroimidazole antimicrobial indicated for the treatment of bacterial vaginosis in non-pregnant women.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
****** ********	*** \ *********	*** **, ****	*******	********	******* *** **** *** *** ****

Chronology Of Events